GDI1 and Intellectual disability: Experimental validations of predicted GIs for gdi-1/GDI1 – a Rho GTPase regulator associated with non-syndromic forms of mental retardation in human – supported the idea that such methodology could be useful to identify therapeutic targets for monogenic diseases from predictive GI networks of lower organisms (Lee et al., 2010a).